Rabbit Recombinant Monoclonal GPR177/WLS antibody. Suitable for WB and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | ICC/IF | IHC-P | |
---|---|---|---|
Human | Tested | Not recommended | Not recommended |
Mouse | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species Mouse | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Regulates Wnt proteins sorting and secretion in a feedback regulatory mechanism. This reciprocal interaction plays a key role in the regulation of expression, subcellular location, binding and organelle-specific association of Wnt proteins (PubMed:34587386). Plays also an important role in establishment of the anterior-posterior body axis formation during development (By similarity).
C1orf139, GPR177, UNQ85/PRO18667, WLS, Protein wntless homolog, Integral membrane protein GPR177, Protein evenness interrupted homolog, Putative NF-kappa-B-activating protein 373, EVI
Rabbit Recombinant Monoclonal GPR177/WLS antibody. Suitable for WB and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Unsuitable for human IHC-P.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Negative control: F9, A20
The expression of WLS is downregulated in response to LGK974 treatment (PMID: 34406391).
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
Exposure time: Lanes 1-3: 37 seconds, Lanes 4-5: 114 seconds.
All lanes: Western blot - Anti-GPR177/WLS antibody [EPR29686-569] (ab323481) at 1/1000 dilution
Lane 1: mIMCD3 (mouse inner medullary collecting duct epithelial cell) whole lysate at 50 µg with NFDM/TBST
Lane 2: F9 (mouse embryonal carcinoma epithelial cell) whole lysate at 50 µg with NFDM/TBST
Lane 3: A20 (mouse reticulum sarcoma B lymphocyte) whole lysate at 50 µg with NFDM/TBST
Lane 4: Untreated A375 (human malignant melanoma epithelial cell) whole lysate at 50 µg with NFDM/TBST
Lane 5: A375 treated with 10uM LGK974 for 96h whole lysate at 50 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 45 kDa, 36 kDa
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
The band above the target band (45 kDa) is expected to be aggregation products.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-GPR177/WLS antibody [EPR29686-569] (ab323481) at 1/1000 dilution
Lane 1: U-87 MG (human glioblastoma-astrocytoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 50 µg with NFDM/TBST
Lane 2: U-87 MG transfected with siRNA specifically targeting WLS whole cell lysate at 50 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 45 kDa, 36 kDa
Exposure time: 70s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Negative control: HepG2, K-562
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (Anti-Vinculin antibody [EPR8185] ab129002) staining at 1/10000 dilution.
All lanes: Western blot - Anti-GPR177/WLS antibody [EPR29686-569] (ab323481) at 1/1000 dilution
Lane 1: HaCaT (human skin keratinocyte) whole lysate at 50 µg with NFDM/TBST
Lane 2: A-204 (human muscle rhabdomyosarcoma cell) whole lysate at 50 µg with NFDM/TBST
Lane 3: HepG2 (human hepatocellular carcinoma epithelial cell) whole lysate at 50 µg with NFDM/TBST
Lane 4: K-562 (human chronic myelogenous leukemia lymphoblast) whole lysate at 50 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 45 kDa, 124 kDa
Exposure time: 26s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com